ABIPAPOGENE SUVAPLASMID
UNII D3XX2X6TBJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Abipapogene Suvaplasmid, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D3XX2X6TBJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2939766-18-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D3XX2X6TBJ

CAS Registry Number

2939766-18-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ABIPAPOGENE SUVAPLASMID

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C123923

National Cancer Institute reference terminology for clinical and research data.

INN ID

13280

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Abipapogene Suvaplasmid. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ABIPAPOGENE SUVAPLASMID

Common Names & Synonyms

ABIPAPOGENE SUVAPLASMID [INN]

DNA (RECOMBINANT MAMMALIAN EXPRESSION VECTOR VB10.16 HUMAN CYTOMEGALOVIRUS PROMOTER PLUS HUMAN C-C MOTIF CHEMOKINE 3-LIKE 1 PROTEIN PRECURSOR FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G3 DIMERIZATION DOMAIN FUSION PROTEIN WITH HUMAN PAPILLOMAVIRUS 16 MUTATION-INACTIVATED E7/E6 FUSION PROTEIN GENE PLUS RABBIT .BETA.-GLOBIN POLYADENYLATION SIGNAL-SPECIFYING)

DNA PLASMID ENCODING A MUTATION-INACTIVATED HUMAN PAPILLOMAVIRUS TYPE 16 E6 / E7 FUSION PROTEIN LINKED TO THE HUMAN CYTOKINE CCL3L1 (CHEMOKINE (C-C MOTIF) LIGAND 3-LIKE 1) VIA A DIMERIZATION MODULE CONSISTING OF UPPER AND LOWER HINGE REGIONS AND CONSTANT HEAVY CHAIN DOMAIN FROM HUMAN IMMUNOGLOBULIN G3 (IGG3). EXPRESSION OF THE TRANSGENE IS UNDER CONTROL OF A CYTOMEGALOVIRUS (CMV) PROMOTER/ENHANCER AND TERMINATED BY A RABBIT .BETA.-GLOBIN POLYADENYLATION SIGNAL. THE PLASMID ALSO CONTAINS A KANAMYCIN RESISTANCE GENE, AN IMMUNOSTIMULATORY (CPG-RICH) SEQUENCE AND A PUC ORIGIN OF REPLICATION

Technical Codes

VB10.16

VB-10.16

External Clinical & Regulatory Resources

Previous UNIID3XLA2EX2N

Next UNIID3Y6DY3X2X